Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bishop A. E., Polak J. M., Chesa P. G., Timson C. M., Bryant M. G., Bloom S. R. Decrease of pancreatic somatostatin in neonatal nesidioblastosis. Diabetes. 1981 Feb;30(2):122–126. doi: 10.2337/diab.30.2.122. [DOI] [PubMed] [Google Scholar]
- Fong T. L., Warner N. E., Kumar D. Pancreatic nesidioblastosis in adults. Diabetes Care. 1989 Feb;12(2):108–114. doi: 10.2337/diacare.12.2.108. [DOI] [PubMed] [Google Scholar]
- Goudswaard W. B., Houthoff H. J., Koudstaal J., Zwierstra R. P. Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon. Hum Pathol. 1986 Jan;17(1):46–54. doi: 10.1016/s0046-8177(86)80154-x. [DOI] [PubMed] [Google Scholar]
- Rayman G., Santo M., Salomon F., Almog S., Paradinas F. J., Pinkhas J., Reynolds K. W., Wise P. H. Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis. J Clin Pathol. 1984 Jun;37(6):651–654. doi: 10.1136/jcp.37.6.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkin T. J., Hammonds P., Mirza I., Bone A. J., Webster K. Graves' disease of the beta cell: glucose dysregulation due to islet-cell stimulating antibodies. Lancet. 1988 Nov 19;2(8621):1155–1158. doi: 10.1016/s0140-6736(88)90232-2. [DOI] [PubMed] [Google Scholar]